(Q54374407)
Statements
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. (English)
Toni K Choueiri
Jorge A Garcia
Gary R Hudes
Walter M Stadler
Laura S Wood
Jayne Gurtler
Shailender Bhatia
Adarsh Joshi
Rebecca R Hozak
Yihuan Xu
Jonathan D Schwartz
John A Thompson
27 February 2014
120
11
1647-1655
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference